Prenetics Global Limited
General ticker "PRE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $96.3M (TTM average)
Prenetics Global Limited follows the US Stock Market performance with the rate: 42.1%.
Estimated limits based on current volatility of 4.8%: low 13.53$, high 14.91$
Factors to consider:
- Total employees count: 400 as of 2022
- Current price 51.4% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.50$, 9.20$]
- 2025-12-31 to 2026-12-31 estimated range: [2.89$, 7.75$]
Financial Metrics affecting the PRE estimates:
- Positive: with PPE of -2.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -39.89 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 79.78 > 63.39
- Positive: Investing cash flow per share per price, % of 53.24 > -0.66
Short-term PRE quotes
Long-term PRE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $13.16MM | $21.74MM | $30.62MM |
| Operating Expenses | $79.19MM | $73.65MM | $78.77MM |
| Operating Income | $-66.02MM | $-51.91MM | $-48.14MM |
| Non-Operating Income | $-159.80MM | $-4.76MM | $-9.56MM |
| Interest Expense | $0.24MM | $0.12MM | $0.20MM |
| R&D Expense | $5.99MM | $11.66MM | $10.92MM |
| Income(Loss) | $-225.82MM | $-56.67MM | $-57.70MM |
| Taxes | $-0.24MM | $-0.27MM | $-7.87MM |
| Profit(Loss)* | $-190.45MM | $-62.72MM | $-46.30MM |
| Stockholders Equity | $237.06MM | $206.36MM | $170.39MM |
| Inventory | $4.53MM | $3.13MM | $6.57MM |
| Assets | $312.13MM | $254.17MM | $213.57MM |
| Operating Cash Flow | $14.51MM | $-13.76MM | $-28.87MM |
| Capital expenditure | $6.34MM | $0.91MM | $1.06MM |
| Investing Cash Flow | $-46.14MM | $-82.95MM | $38.54MM |
| Financing Cash Flow | $143.32MM | $-4.70MM | $-3.34MM |
| Earnings Per Share** | $-37.57 | $-5.58 | $-3.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.